Cushing's syndrome is the third most commonly diagnosed endocrinopathy in dogs, with a prevelance of around 0.2% and is associated with a poorer qualty of life (QoL). Trilostane is the most commonly prescribd treated for Cushing's syndrome in the UK, and this treatment improves but does not normalise QoL. This lecture will present possible explanations why this treatment does not return QoL to normal from the viewpoint of each of the three different presenters.
Internal Medicine; Surgery; Neurology
Presented by Christopher Scudder - Senior Lecturer, Royal Veterinary College, Joe Fenn - Senior Lecturer in Veterinary Neurology and Neurosurgery, Royal Veterinary College, David Church - Deputy Principal and Professor of Small Animal Studies, Royal Veterinary College
Presented at London Vet Show 2023
RVC Clinical Theatre 2
Friday, 17 November 2023, 10:40 - 11:25
Please note this session is not RACE-approved but you can still earn a CPD certificate